Assignee
INSIGNIS THERAPEUTICS INC
US·2 granted patents·4 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
6 records- 0177US2025000821A1Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0268US11213496B2Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·0 cites·27 claims
- 0367US2022193010A1Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0462US11213484B2Dipivefrin orally disintegrating tablet formulationsINSIGNIS THERAPEUTICS INC·Filed 2020·Granted Jan 4, 2022·0 cites·21 claims
- 0562US2022071898A1Dipivefrin orally disintegrating tablet formulationsINSIGNIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0654US2025387363A1Liquid epinephrine prodrug formulations and liquid epinephrine formulationsINSIGNIS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →